Respiratory distress syndrome in Switzerland: Comparison of the 1984 with the 1974 data

Baeckert, P; Ackermann‐Liebrich, Ursula; Duc, Gabriel

doi:10.1007/bf01369942

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…RD was defined as presence of at least two of the following criteria: tachypnea (>60 breaths per minute), central cyanosis in room air, expiratory grunting, subcostal, intercostal or jugular retractions and nasal flaring (6). This definition is entirely based on clinical observation irrespective of the etiology of RD and is used in all neonatal units in Switzerland since 1972 until today.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Increasing incidence of respiratory distress in neonates

Ersch

Roth‐Kleiner

Baeckert³

et al. 2007

Acta Paediatrica

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 99%

“…A first survey via questionnaires was sent to all neonatal units in Switzerland to include all neonatal admissions from January 1, 1974 to December 31, 1974. This survey was repeated for the years 1984, 1994 and 2004 (5,6). Data collections were performed retrospectively from hospital based statistics.…”

Section: Methodsmentioning

confidence: 99%

Increasing incidence of respiratory distress in neonates

Ersch

Roth‐Kleiner

Baeckert³

et al. 2007

Acta Paediatrica

Self Cite

View full text Add to dashboard Cite

show abstract

“…Among these infants with GA ≥ 32 weeks, respiratory distress (RD) is a common cause for hospitalization [ 3 – 5 ]. RD is defined as the presence of at least two clinical symptoms for a minimum duration of 15 min, which may include tachypnea (respiratory rate > 60/min), subcostal and/or intercostal retractions, expiratory grunting, nasal flaring, and central cyanosis in room air [ 6 ]. A prospective study conducted in Switzerland reported that hospitalized neonates with GA ≥ 32 weeks accounted for 85.4% of all neonates with RD [ 7 ].…”

Section: Introductionmentioning

confidence: 99%

High-flow nasal cannula (HFNC) vs continuous positive airway pressure (CPAP) vs nasal intermittent positive pressure ventilation as primary respiratory support in infants of ≥ 32 weeks gestational age (GA): study protocol for a three-arm multi-center randomized controlled trial

Zhou,

Xiong,

Tang

et al. 2023

Trials

View full text Add to dashboard Cite

Background Health problems in neonates with gestational age (GA) ≥ 32 weeks remain a major medical concern. Respiratory distress (RD) is one of the common reasons for admission of neonates with GA ≥ 32 weeks. Noninvasive ventilation (NIV) represents a crucial approach to treat RD, and currently, the most used NIV modes in neonatal intensive care unit include high-flow nasal cannula (HFNC), continuous positive airway pressure (CPAP), and nasal intermittent positive pressure ventilation. Although extensive evidence supports the use of NIPPV in neonates with a GA < 32 weeks, limited data exist regarding its effectiveness in neonates with GA ≥ 32 weeks. Therefore, the aim of this study is to compare the clinical efficacy of HFNC, CPAP, and NIPPV as primary NIV in neonates with GA ≥ 32 weeks who experience RD. Methods This trial is designed as an assessor-blinded, three-arm, multi-center, parallel, randomized controlled trial, conducted in neonates ≥ 32 weeks’ GA requiring primary NIV in the first 24 h of life. The neonates will be randomly assigned to one of three groups: HFNC, CPAP or NIPPV group. The effectiveness, safety and comfort of NIV will be evaluated. The primary outcome is the occurrence of treatment failure within 72 h after enrollment. Secondary outcomes include death before discharge, surfactant treatment within 72 h after randomization, duration of both noninvasive and invasive mechanical ventilation, duration of oxygen therapy, bronchopulmonary dysplasia, time to achieve full enteral nutrition, necrotizing enterocolitis, duration of admission, cost of admission, air leak syndrome, nasal trauma, and comfort score. Discussion Currently, there is a paucity of data regarding the utilization of NIPPV in neonates with GA ≥ 32 weeks. This study will provide clinical evidence for the development of respiratory treatment strategies in neonates at GA ≥ 32 weeks with RD, with the aim of minimizing the incidence of tracheal intubation and reducing the complications associated with NIV. Trial registration Chinese Clinical Trial Registry: ChiCTR2300069192. Registered on March 9, 2023, https://www.chictr.org.cn/showproj.html?proj=171491.

show abstract

Respiratory distress syndrome in Switzerland: Comparison of the 1984 with the 1974 data

Cited by 2 publications

References 0 publications

Increasing incidence of respiratory distress in neonates

Increasing incidence of respiratory distress in neonates

High-flow nasal cannula (HFNC) vs continuous positive airway pressure (CPAP) vs nasal intermittent positive pressure ventilation as primary respiratory support in infants of ≥ 32 weeks gestational age (GA): study protocol for a three-arm multi-center randomized controlled trial

Contact Info

Product

Resources

About